These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

371 related items for PubMed ID: 19201343

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Feasibility, tolerability, and outcomes of nebulized liposomal amphotericin B for Aspergillus infection prevention in lung transplantation.
    Monforte V, Ussetti P, Gavaldà J, Bravo C, Laporta R, Len O, García-Gallo CL, Tenorio L, Solé J, Román A.
    J Heart Lung Transplant; 2010 May; 29(5):523-30. PubMed ID: 20061165
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Efficiency and safety of inhaled amphotericin B lipid complex (Abelcet) in the prophylaxis of invasive fungal infections following lung transplantation.
    Borro JM, Solé A, de la Torre M, Pastor A, Fernandez R, Saura A, Delgado M, Monte E, Gonzalez D.
    Transplant Proc; 2008 Nov; 40(9):3090-3. PubMed ID: 19010204
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Safety of aerosolized liposomal versus deoxycholate amphotericin B formulations for prevention of invasive fungal infections following lung transplantation: a retrospective study.
    Lowry CM, Marty FM, Vargas SO, Lee JT, Fiumara K, Deykin A, Baden LR.
    Transpl Infect Dis; 2007 Jun; 9(2):121-5. PubMed ID: 17461997
    [Abstract] [Full Text] [Related]

  • 8. Meta-analysis of nebulized amphotericin B to prevent or treat pulmonary aspergillosis in immunosuppressed animals.
    Ho KM, Duff O, Chambers D, Murray R.
    Transpl Infect Dis; 2008 Jun; 10(3):168-76. PubMed ID: 18194368
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Amphotericin B disposition after aerosol inhalation in lung transplant recipients.
    Marra F, Partovi N, Wasan KM, Kwong EH, Ensom MH, Cassidy SM, Fradet G, Levy RD.
    Ann Pharmacother; 2002 Jan; 36(1):46-51. PubMed ID: 11816256
    [Abstract] [Full Text] [Related]

  • 13. [Usefulness of liposomal amphotericin B for the prophylaxis of fungal infection in solid organ transplant recipients].
    López-Medrano F, Díaz-Pedroche C, Lumbreras C, Aguado JM.
    Rev Esp Quimioter; 2005 Mar; 18(1):14-20. PubMed ID: 15915227
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. A survey of anti-fungal management in lung transplantation.
    Dummer JS, Lazariashvilli N, Barnes J, Ninan M, Milstone AP.
    J Heart Lung Transplant; 2004 Dec; 23(12):1376-81. PubMed ID: 15607667
    [Abstract] [Full Text] [Related]

  • 17. Prospective interventional study to evaluate the efficacy and safety of liposomal amphotericin B as prophylaxis of fungal infections in high-risk liver transplant recipients.
    Castroagudín JF, Pontón C, Bustamante M, Otero E, Martínez J, Tomé S, Conde R, Segade FR, Delgado M, Brage A, Galbán C, Varo E.
    Transplant Proc; 2005 Nov; 37(9):3965-7. PubMed ID: 16386598
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.